Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

C. (Linda) M. C. van Campen* and Frans C. Visser, Kenneth J. Friedman, Academic Editor, Patricia A. Fennell, Academic Editor, Derek F. H. Pheby, Academic Editor, Evan Spivack, Academic Editor, James M. Oleske, Academic Editor, Nancy Klimas, Academic…[...]

Read More

Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies

Melanie Dani,  Andreas Dirksen, Patricia Taraborrelli,  Miriam Torocastro, Dimitrios Panagopoulos, Richard Sutton, and Phang Boon Lim Clin Med (Lond). 2021 Jan; 21(1): e63–e67.  doi: 10.7861/clinmed.2020-0896 PMCID: PMC7850225 PMID: 33243837 ABSTRACT The SARS-CoV-2 (COVID-19) pandemic has caused unprecedented morbidity, mortality and global disruption.…[...]

Read More

Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Published online 2021 Dec 24. doi: 10.3390/medicina58010028 PMCID: PMC8778312 PMID: 350563 C. (Linda) M. C. van Campen,1,* Peter C. Rowe,2 and Frans C. Visser1 Olli J. Polo, Academic Editor Abstract Background and Objectives: Symptoms and hemodynamic findings during…[...]

Read More

Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies

Melanie Dani, consultant geriatrician,A Andreas Dirksen, specialist nurse in syncope,B Patricia Taraborrelli, specialist nurse in syncope,B Miriam Torocastro, syncope research nurse,C Dimitrios Panagopoulos, clinical research fellow in cardiology,D Richard Sutton, professor of clinical cardiology,E and Phang Boon Lim, consultant cardiologistF Clin Med (Lond). 2021 Jan;…[...]

Read More

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious…[...]

Read More